Affinity chromatographic screening of soluble combinatorial peptide libraries

Affinity chromatography using immobilized S‐protein was used for the screening of affinity peptide ligands from two soluble peptide libraries. Peptide library I consisted of octamers with glycine (G) at both termini of each peptide, i.e. GXXXXXXG. The six center positions were constructed using rand...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biotechnology and bioengineering 1999-06, Vol.63 (6), p.633-641
Hauptverfasser: Huang, Ping Y., Carbonell, Ruben G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Affinity chromatography using immobilized S‐protein was used for the screening of affinity peptide ligands from two soluble peptide libraries. Peptide library I consisted of octamers with glycine (G) at both termini of each peptide, i.e. GXXXXXXG. The six center positions were constructed using random sequences of six L‐amino acids (Y, N, F, E, V, and L). Peptide library II also consisted of octamers but with glycine and valine (V) at both termini of each peptide (GVZZZZVG). The four variable center positions of peptide library II were random sequences of 18 L‐amino acids. Peptides that were retained specifically on the immobilized S‐protein column were eluted by 2% acetic acid. The peptides in the acid eluate were further separated using reversed‐phase HPLC. Each separated peptide fraction was collected and the peptide sequences deconvoluted by mass spectrometry (MS/MS). The screenings of peptide libraries I and II resulted in 12 and 7 affinity peptides, respectively. Eight out of the twelve peptides from peptide library I contained the clear consensus sequence NFEV. Peptide library II resulted in affinity peptides with the sequences GVNFEVVG, GVNFTVVG and GVFFEL(I)VG. The advantages and limitations of affinity chromatography in peptide library screening are discussed. © 1999 John Wiley & Sons, Inc. Biotechnol Bioeng 63: 633–641, 1999.
ISSN:0006-3592
1097-0290
DOI:10.1002/(SICI)1097-0290(19990620)63:6<633::AID-BIT1>3.0.CO;2-C